Best Nintedanib Soft Gelatin Capsules in India— The ideal medicine approved for the administration of progressive lung diseases is used for the treatment of certain progressive lung diseases, such as idiopathic pulmonary fibrosis (IPF) and other approved types of fibrosing interstitial lung diseases (FILD), known as Nintedanib soft gelatin capsules. Nintedanib is a tyrosine kinase inhibitor (TKI), which is thought to block (inhibit) signalling pathways associated with tissue scarring. It can also help to slow lung function changes in eligible patients but does NOT reverse damage to the lungs or treat pulmonary fibrosis.
Individuals who are looking up the Best Nintedanib Soft Gelatin Capsules in India might find different brands of nintedanib capsules. The product(s) may vary in brand, packaging, stock, and/or cost. But there’s no reason why a brand can’t be better just because it’s more advertised or less costly.
List of Best Nintedanib Soft Gelatin Capsules in India
NINGET 100 Softgel Capsules by Healthgate is an option to consider among Nintedanib soft gelatin capsules in India for pharmaceutical distributors and PCD pharma franchise partners seeking to expand their respiratory medicine portfolio. Compared with alternatives such as Cyendiv and Nintabid, NINGET 100 offers distributors an additional brand to evaluate based on product documentation, supply availability, and commercial terms. Nintedanib should be used only under specialist medical supervision.
Best for: PCD Pharma Franchise | Pharmaceutical Distribution | Respiratory Medicine Portfolio
The selection process should consider the following criteria: the strength of the product as prescribed, product authorization confirmed, manufacturing quality, traceable supply, and professional medical advice. Nintedanib is usually marketed as 100 mg capsules and 150 mg capsules but varies with product/markets.

- Ninget 100 softgel capsule is another brand of the drug, a reference brand of the Boehringer Ingelheim drug.
- It is prescribed for conditions that have been approved, including certain other ongoing fibrosing lung diseases and idiopathic pulmonary fibrosis.
- Nintedanib also may be used for specific indications for cancer therapy, depending on local prescribing information.
- When assessing the strength, authorized source of supply, packaging of Ninget 100, and the patient information leaflet.
- Its use is not a “must” brand but may be a useful reference only; the choice of treatment is the doctor’s responsibility.
Cyendiv
- In India, Cyendiv is the nintedanib brand promoted by Boehringer Ingelheim.
- The product listing contains 150 mg soft gelatin capsules, and there are also product listings for 100 mg presentations.
- It has been linked to therapy for IPF and a few other accepted indications.
- They should inquire of current availability since stock varies from pharmacy to pharmacy.
- A healthcare professional should take into consideration the clinical indication, strength, tolerability, and product information relevant to a specific product prior to recommending treatment.
Nintabid
- J. B. Chemicals and Pharmaceuticals is the marketer of Nintabid.
- The Indian Medicine Listing gives the Indian drug details of ailments with 100 mg and 150 mg presentations in the form of soft gelatin capsules named Nintabid.
- When a specialist prescribes nintedanib and it is available through an authorized pharmacy, it may be considered for this brand.
- The patients must check the packaging as well as the directions for use, following the instructions provided.
- Distributors should verify authorization of the product, batch traceability, and ongoing supply.
Nintib
- Nintib is the Cipla brand of the nintedanib drug.
- There is no 200 mg soft gelatin capsule listed in Indian medicines.
- Examine when buying Nintib; buying listings may vary by pack configuration of the dosage form and strength.
- The product should come from a licensed supplier, and patients should not change their source of nintedanib to a different product brand without consulting their treating specialist.
Nintena
- Nintena is a drug sold by Sun Pharmaceutical Industries.
- The medicine listings for India show 100 mg and 150 mg soft gelatin capsule presentations.
- Patients’ primary concerns are medication dosage, medication correctness, and compliance with the treatment regimen.
- Prior to procurement, it is important for healthcare providers and distributors to ensure that they have reliable information about the current product, packaging information, and the channel of supply for this product.
Nindanib
- Nindanib is sold by Glenmark Pharmaceuticals and has been approved as a nintedanib in India.
- Holdings come in soft gelatin capsules, 100 mg and 150 mg.
- It applies to individuals undertaking research into branded nintedanib products for whom it has a valid indication role (e.g., IPF).
- Like other brands, suitability is a matter of clinical conditions along with the combination of the patient’s prescription.
Fibnib
- Fibnib is a nintedanib product belonging to the company called Alkem Laboratories. The 100 mg and 150 mg soft gelatin capsule presentations are listed in Indian pharmacies.
- If you’re looking into the fingerprint of a pack called Fibnib, check the manufacturer information on the specific pack, whether it’s available at the time, and the strength that the doctor prescribed.
- Stock, prices, and availability of pharmacy products may change, and the availability of a listed product on the internet does not imply availability in the pharmacy.
Fibronib
- Another brand of nintedanib has started listing in Indian pharmacies named Fibronib. It comes as a 100 mg and 150 mg version.
- The company can be mentioned in a market comparison for individuals making research about nintedanib products.
- But it’s not proof that it’s clinically better than other brands.
- Purchasers are advised to verify the manufacturer, product authorization, packaging, and availability of the product before purchase.
Idofnib
- Idofenib belongs to the class of medications nintedanib.
- May be used as a prescription in the appropriate presentation if the presentation is authorized and available.
- Patients must adhere to the doctor’s prescription and report side effects.
- Focusing only on brand should not be evaluated by a distributor but by his/her qualification and product traceability.
Mantedanib
- Mantedanib is available under the Mankind Pharma brand and listed in Indian medicine, which is sold in softgel capsule form of 100 mg and 150 mg.
- Compare the active ingredient, strength of prescription, and indication approved for mantedanib to other brands of nintedanib products.
- There may be differences between suppliers regarding price, packaging, and availability. Do not take treatment decisions without specialist supervision.
Frequently Asked Questions (FAQ)
Which available strengths are there?
One size that gets a lot of prescriptions based on it is 100 mg and 150 mg. This requires the correct dosage and timing, which depends on the approved indication, individual reaction, and the assessment of the specialized prescriber.
Do all Nintedanib brand products work as well?
Just a brand name is no evidence of comparative effectiveness. Authorization of the product, quality, the prescribed regimen, and patient-specific factors are important. Patients should never change brands without talking to their healthcare professional.
What are the factors the distributor must look at before purchasing the Nintedanib capsules?
Distributors are required to check the manufacturer, the validity of the licenses, the product authorization, the batch traceability, package integrity, expiration period, and the integrity of the supply chain. Availability and commercial terms for the ongoing stocks should be verified directly with authorized suppliers.
What are the important precautions when taking Nintedanib?
Diarrhea, nausea, vomiting, abdominal discomfort, and elevated liver enzymes are possible side effects of nintedanib. These are serious side effects that require medical supervision and appropriate monitoring of patients. Review the prescribing information for other warnings, interactions, and precautions for pregnancy.